BioLife Solutions, Inc.
BLFS
$21.90
$0.914.34%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 12.46M | -1.70M | -22.78M | -10.22M | -14.96M |
| Total Depreciation and Amortization | -1.47M | 2.32M | 2.44M | 2.28M | -2.28M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | 0.00 |
| Total Other Non-Cash Items | -10.21M | 5.41M | 24.15M | 6.11M | 14.19M |
| Change in Net Operating Assets | 857.00K | -1.22M | 2.64M | -2.64M | 5.36M |
| Cash from Operations | 1.65M | 4.80M | 6.46M | -4.48M | 2.31M |
| Capital Expenditure | -802.00K | -1.55M | 820.00K | -820.00K | -2.38M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 74.44M | -133.00K | -14.26M | 599.00K | 6.34M |
| Cash from Investing | 73.64M | -1.68M | -13.44M | -221.00K | 3.96M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -3.43M | -2.71M | 241.00K | -241.00K | 185.00K |
| Issuance of Common Stock | 65.00K | 46.00K | -- | -- | 10.38M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -725.00K | 1.63M | -945.00K | -711.00K | -725.00K |
| Cash from Financing | -4.09M | -1.04M | -704.00K | -952.00K | 9.84M |
| Foreign Exchange rate Adjustments | 29.00K | 36.00K | 0.00 | -65.00K | 63.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 71.23M | 2.12M | -7.68M | -5.71M | 16.17M |
